Learn More
BACKGROUND We investigated the addition of rituximab to dose-dense and high-dose chemotherapy with autologous stem cell transplantation in patients with untreated poor-prognosis diffuse large B-cell(More)
Little is known regarding the activity of tyrosine kinase inhibitors (TKis) on chronic myeloid leukemia (CML) clonal evolution (CE). We treated 10 CE CML patients in either hematologic chronic (8(More)
In this study, we evaluated the possible cross-talk between glucocorticoid (GC)-induced leucine zipper (Gilz) and caspase-8 in dexamethasone (Dex)-treated thymocytes. We determined that expression of(More)
Prognosis of patients suffering from secondary central nervous system (CNS) lymphoma is dismal. Intracranial spread of a lymphoma arising in adjacent extranodal tissues is a rare event. A 32-year-old(More)
e18555 Background: CNS lymphoma is an aggressive tumor. HD-MTX-TMZ appears to be an effective and relatively safe regimen. We report our preliminary experience with HD-MTX-TMZ plus concomitant IT LC(More)
Treatment of central nervous system (CNS) lymphoma remains challenge for clinicians. Historically, whole-brain radiotherapy WBRT) has been the cornerstone of treatment for brain lymhomas. However,(More)
  • 1